Summary | However, sales within biopharmaceuticals declined by
24 percent to 4.7 billion kroner.Novo Nordisk is the world
leader in diabetes care with a global value market share of 27
percent.It is also the world's largest insulin maker with 46
percent market share.(1 U.S. dollar = 6.81| People's Daily
Online | China.org.cn| CNTV | China.| Global Times | Ecns.cn | ...
24 percent to 4.7 billion kroner.Novo Nordisk is the world
leader in diabetes care with a global value market share of 27
percent.It is also the world's largest insulin maker with 46
percent market share.(1 U.S. dollar = 6.81| People's Daily
Online | China.org.cn| CNTV | China.| Global Times | Ecns.cn | ...
en.ce.cn | 14 May 2017